ELIZABETH SHAWA: Open Payments
NPI 1851036859 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 16 payments from 11 companies in 2025. Trend: 2023 $424 · 2024 $145 · 2025 $515
Food & beverage: $389Education: $126
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $152 |
| Janssen Biotech, Inc. | 2 | $118 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| Syndax Pharmaceuticals, Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Incyte Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Trodelvy, DARZALEX, KEYTRUDA, ENHERTU, NINLARO, JAKAFI, BLENREP, CARVYKTI.
Industry payments across TN — which companies pay providers there.
